Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Stanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Respirology. 2022 Aug;27(8):661-668. doi: 10.1111/resp.14305. Epub 2022 Jun 7.
Bats are likely the primary source of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Minks are highly susceptible to infection by SARS-CoV-2. Transmission from asymptomatic individuals was estimated to account for over 50% of all transmissions of coronavirus disease 2019 (COVID-19) cases. SARS-CoV-2 is evolving towards more efficient aerosol transmission. Remdesivir, baricitinib, tocilizumab and dexamethasone are frequently used for the treatment of patients with respiratory failure due to COVID-19. There is a rising incidence of non-tuberculous Mycobacterium pulmonary disease globally, with a higher prevalence in Asian countries than in the Western world. Protracted bacterial bronchitis is a common cause of chronic productive cough in childhood. Re-emergence of respiratory syncytial virus may occur after the relaxation of infection control measures and the reopening of borders during COVID-19 pandemic.
蝙蝠可能是严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的主要来源。水貂极易感染 SARS-CoV-2。无症状感染者的传播估计占所有 2019 年冠状病毒病(COVID-19)病例传播的 50%以上。SARS-CoV-2 正朝着更有效的气溶胶传播方向进化。瑞德西韦、巴瑞替尼、托珠单抗和地塞米松常用于治疗因 COVID-19 导致呼吸衰竭的患者。全球非结核分枝杆菌肺病的发病率正在上升,亚洲国家的患病率高于西方国家。迁延性细菌性支气管炎是儿童慢性湿性咳嗽的常见原因。呼吸道合胞病毒在 COVID-19 大流行期间感染控制措施放松和边境重新开放后可能会再次出现。